Catalyst Wire Dossier Catalyst Wire Dossier

SLYND

DROSPIRENONE · Exeltis USA, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SLYND, covering 2019-05-23 to 2019-05-23. Get the full timeline:

Most recent: FDA Approved: SLYND — Original Application (Exeltis USA, Inc.)

See pricing